Enlyte Drug Trend Report: Migraine Med Use Soars in Comp Despite Overall Drop in Scripts
Annual PBM report shows increases in overall migraine meds use by nearly 9%, while opioids drop by almost 8% SAN...
Disability
Infinum Opens Empathy Lab to Media for Hands-On Accessibility Experience
Infinum recently welcomed media representatives to its Empathy Lab, offering a firsthand look at the digital accessibility challenges people with...
Acentra Health Awarded $27.5 Million Contract from California Medicaid to Continue Providing Preadmission Screening and Resident Review (PASRR) Services
Award follows new contracts in Kansas and Washington and expands the company’s PASRR services for long-term care assessments to eight...
Acentra Health Awarded $27.5 Million Contract from California Medicaid to Continue Providing Preadmission Screening and Resident Review (PASRR) Services
Award follows new contracts in Kansas and Washington and expands the company’s PASRR services for long-term care assessments to eight...
Four-year Follow-up Data on SPRINT® PNS for Low Back Pain Highlights Sustained Pain Relief Avoiding Costly and Invasive Treatments
CLEVELAND, April 29, 2025 (GLOBE NEWSWIRE) -- SPR announced the publication of long-term follow-up survey data from a prospective, multicenter...
Four-year Follow-up Data on SPRINT® PNS for Low Back Pain Highlights Sustained Pain Relief Avoiding Costly and Invasive Treatments
CLEVELAND, April 29, 2025 (GLOBE NEWSWIRE) -- SPR announced the publication of long-term follow-up survey data from a prospective, multicenter...
American Foundation for Suicide Prevention Hosts 36th Annual Lifesavers Gala
Eric & Terry Murray, parents of PGA professional golfer Grayson Murray, to receive Survivors of Suicide Loss Lifesaver Award NEW YORK,...
Kii Health announces the addition of enhanced mental health support to its industry-leading platform
Evidence-based care solution reduces the barriers to accessing quality care for the most prevalent mental health challenges TORONTO, April 28,...
Levicept Presents Positive Phase II Data for Novel Neurotrophin-3 Inhibitor, LEVI-04, at 2025 World Congress on Osteoarthritis
Plenary presentation of data showing primary efficacy endpoint met – significant analgesia across all dosesSignificant improvement in all signs and...
Baijiayun Announces Plan to Invest Tens of Millions of Dollars Over Five Years to Build New Ecosystem for Autism Rehabilitation
BEIJING, April 25, 2025 /PRNewswire/ -- Baijiayun Group Ltd ("Baijiayun" or the "Company") (NASDAQ: RTC), a one-stop AI video solution...
Baijiayun Announces Plan to Invest Tens of Millions of Dollars Over Five Years to Build New Ecosystem for Autism Rehabilitation
BEIJING, April 25, 2025 /PRNewswire/ -- Baijiayun Group Ltd ("Baijiayun" or the "Company") (NASDAQ: RTC), a one-stop AI video solution...
Somatic Health and Kinetisense to Commence a Groundbreaking Clinical Study with Rothman Orthopaedics
NEW YORK, April 24, 2025 /PRNewswire/ -- Somatic Health and Kinetisense are launching a cutting edge clinical study in partnership with...
KONZA National Network Joins Missouri eLTSS Project Phase 2 to Advance Person-Centered Care for Individuals with IDD
TOPEKA, Kan., April 24, 2025 /PRNewswire/ -- KONZA National Network is proud to announce its partnership in Phase 2 of the...
Ace Vision Group Announces Initial Close of $29.4 Million Series B Financing Round
Funding supports the commercial product development of VisioLite® Device and Laser Scleral Microporation Human Clinical Study. Capital raised to date...
CMA Physician Services unveils MedWay, a new administrative support service to help independent practices thrive
New solution simplifies practice management, enhances efficiency, and preserves autonomy for healthcare providers. SACRAMENTO, Calif., April 22, 2025 /PRNewswire/ --...
Enlivex Announces Completion of Enrollment In The Phase II stage Of Its Phase I/II Trial Evaluating Allocetra In Patients With Moderate To Severe Knee Osteoarthritis
Nes-Ziona, Israel, April 21, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy...
Therabody Introduces Performance Team to Champion the Future of Sport and Recovery
The first six athletes are redefining what it means to push limits, build community, and prioritize recovery in their pursuit...
MYndspan Appoints Holmusk Founder and CEO Nawal Roy as Strategic Advisor
Following momentum from its Crowdcube campaign and investment from EMOTIV, MYndspan is deepening its commitment to evidence-based brain health LONDON,...
Ace Vision Group to Host “Take the Presbyopia Challenge” Event and Present Scientific Posters at 2025 ASCRS Annual Meeting
BOSTON, April 10, 2025 (GLOBE NEWSWIRE) -- Ace Vision Group, Inc. (“AVG” or “the Company”), an emerging medical device company on...
Alterity Therapeutics Presents Encouraging New Data from its ATH434 Phase 2 Trial in Multiple System Atrophy at the American Academy of Neurology Annual Meeting
– Clinically Meaningful Efficacy Observed on Multiple Assessments – – Confirmed Target Engagement with Reduced Iron Signal in MSA Affected...